{"id":"W2620677458","doi":"10.1016/j.jcjd.2017.01.009","title":"Considerations for Initiating a Sodium-Glucose Co-Transporter 2 Inhibitor in Adults With Type 2 Diabetes Using Insulin","year":2017,"lang":"en","type":"review","venue":"Canadian Journal of Diabetes","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta; Université de Montréal; Winnipeg Regional Health Authority; Montreal Clinical Research Institute; Health Sciences Centre; Mount Sinai Hospital; Alberta Health Services; LMC Diabetes & Endocrinology (Canada); Alberta Health; University of Manitoba","funders":"Regeneron Pharmaceuticals; Novo Nordisk; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Transporter; Insulin; Type 2 diabetes; Sodium; Diabetes mellitus; Internal medicine; Endocrinology; Pharmacology; Biochemistry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009051817,0.0004765043,0.001527147,0.0009536203,0.0003016324,0.001136914,0.0007853968,0.001589407,0.003397893],"category_scores_gemma":[0.002784251,0.0001849092,0.001231579,0.0008666154,0.0003017091,0.0008583132,0.0003108573,0.00282484,0.0005383424],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008380162,"about_ca_system_score_gemma":0.002272296,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006328013,"about_ca_topic_score_gemma":0.01777385,"domain_scores_codex":[0.9995259,0.0001207575,0.0001225221,0.00004696958,0.0001507958,0.00003302715],"domain_scores_gemma":[0.9987603,0.000792223,0.0002219469,0.00001018962,0.0001499116,0.00006546806],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003938467,0.0001066441,0.002127254,0.02246946,0.0004297698,0.0006731844,0.0001019751,0.000329558,0.0003641806,0.003424811,0.06692327,0.902656],"study_design_scores_gemma":[0.0006570437,0.0002480492,0.01023025,0.08714868,0.002992992,0.005039773,0.0004249913,0.000404396,0.0003668781,0.006018511,0.8863677,0.0001008275],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002023507,0.9966061,0.00007566767,0.001866567,0.0002727123,0.000004778236,0.00001805225,0.000004845976,0.0009489152],"genre_scores_gemma":[0.002899204,0.9934251,0.0005132051,0.002232201,0.0005383103,0.00001251313,0.00005612027,0.000001897599,0.0003213992],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006328013,"threshold_uncertainty_score":0.01258236,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07830772161440945,"score_gpt":0.3219295847188609,"score_spread":0.2436218631044514,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}